Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2006 1
2013 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
Yuen KC, Dunger DB. Yuen KC, et al. Growth Horm IGF Res. 2006 Jul;16 Suppl A:S55-61. doi: 10.1016/j.ghir.2006.03.001. Epub 2006 Apr 18. Growth Horm IGF Res. 2006. PMID: 16624605 Review.
Supraphysiological doses of growth hormone (GH) therapy are generally thought to antagonize the effects of insulin, whereas the insulin-like growth factor I (IGF-I) potentiates insulin-like actions. ...Growth h …
Supraphysiological doses of growth hormone (GH) therapy are generally thought to antagonize the effects of insulin, whe …
Effect of recombinant insulin-like growth factor-1 treatment on short-term linear growth in a child with Majewski osteodysplastic primordial dwarfism type II and hepatic insufficiency.
Faienza MF, Acquafredda A, D'Aniello M, Soldano L, Marzano F, Ventura A, Cavallo L. Faienza MF, et al. J Pediatr Endocrinol Metab. 2013;26(7-8):771-4. doi: 10.1515/jpem-2012-0397. J Pediatr Endocrinol Metab. 2013. PMID: 23612698
In consideration of the low levels of insulin-like growth factor-1 (IGF-1) as well as of hepatic insufficiency, we started the treatment with recombinant human IGF-1 (rhIGF-1) at the dose of 0.04 mg/kg in 2 doses/day, with a …
In consideration of the low levels of insulin-like growth factor-1 (IGF-1) as well as of hepatic i …
Modulation of IGF-I receptors by exogenous hGH treatment in constitutionally short children.
Eshet R, Klinger B, Silbergeld A, Laron Z. Eshet R, et al. Clin Endocrinol (Oxf). 1993 Dec;39(6):687-93. doi: 10.1111/j.1365-2265.1993.tb02428.x. Clin Endocrinol (Oxf). 1993. PMID: 8287588
OBJECTIVE: To study the in-vivo regulation of IGF-I binding sites on erythrocytes (RBC) following administration of growth hormone (hGH) to constitutionally short children. Recently, owing to biosynthetic techniques, treatment with hGH has been administered not only to chi …
OBJECTIVE: To study the in-vivo regulation of IGF-I binding sites on erythrocytes (RBC) following administration of growth hormone (h …